Page 249 - Haematologica Vol. 110 - January 2025
P. 249
LETTER TO THE EDITOR AB
CD
Figure 2. Event-free survival predicted by the molecular prognostic risk signature and Krüger’s model in patients with acute myeloid leukemia. (A, B) Event-free survival predicted by the molecular prognostic risk signature in patients with newly diagnosed acute myeloid leukemia (A) and in those with relapsed or refractory disease (B). (C) Event-free survival according to Krüger’s model in the relapsed/refractory cohort. (D) C-index comparisons. ND: newly diagnosed; mPRS: molecular prognostic risk signa- ture; RR: relapsed or refractory; ELN: European LeukemiaNet; EFS: event-free survival; 95% CI: confidence interval; HR: hazard ratio.
Haematologica | 110 January 2025
241
